Home monitoring for babies after heart surgery
Official title: Cardiopediatric Home Monitoring Tool
Run by Nantes University Hospital · NCT06741189 · Data updated 2026-11-12
This project tests a home monitoring system with telemedicine to help babies up to 3 years old who had congenital heart surgery to catch problems early and keep them safe at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Minutes to 36 Months |
| Sex | All |
| Enrollment | 186 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Status | Recruiting |
| Started | October 30, 2025 |
| Main results expected | July 30, 2028 |
| Study ends | July 30, 2028 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT06741189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants and young children (0-36 months) with congenital heart defects who had cardiac surgery at Nantes University Hospital and have caregiver consent and home connectivity.
✕Probably not a fit
Children without stable home connectivity or those with contraindicating clinical/family situations may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study aims to see whether a home monitoring program, using validated sensors and an alert system tailored to each care pathway, alongside standard postoperative care, can reduce morbidity and mortality in neonates and young children after cardiac surgery. It employs a protocolized medical response to alerts generated by the home tool. The population affected includes patients with congenital heart defects, focusing on high-risk postoperative periods such as interstage periods in staged palliation. The trial is conducted at Nantes University Hospital, leveraging the Exolis home platform for remote connectivity. Primary endpoints and statistical specifics are not provided in the available material.
Why it matters
Potential benefit: If successful, patients may experience earlier detection of complications and improved post-surgical outcomes through closer, at-home monitoring.
How similar studies have gone: Prior experiences with home telemedicine and sensor-based monitoring show potential, but this exact integrated approach remains relatively novel in this patient group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 0 and 36 months inclusive * With a congenital heart defect * Underwent cardiac surgery at Nantes University Hospital * Affiliated to a social security scheme * Free, informed and written consent of the 2 holders of parental authority Non Inclusion Criteria: * Clinical or family situation contraindicating a return home * Physical inability to connect to the Exolis platform at home * Insufficient understanding on the part of those with parental authority * Extracardiac co-morbidities responsible for organ failure requiring repeated * Hospitalisation for non-cardiovascular reasons (e.g. severe renal failure, neurological neurological deficit, complex immune deficiency, etc). * Patient and/or parents under legal protection
Where it's running
-
CHU de Nantes
Nantes, France Recruiting
Study contacts
- Study coordinator: Alban-Elouen Baruteau, Pr
- Email: albanelouen.baruteau@chu-nantes.fr
- Phone: +33
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting skin samples for patients with congenital heart disease
This study is collecting skin samples from adults with congenital heart disease to help make it easier to find patients for future treatments.
-
Automated assessment of fetal heart function in babies with heart diseases
This study is testing if new ways to check fetal heart function can help doctors understand heart problems in babies with congenital heart defects compared to healthy babies.
-
Monitoring oxygen levels in newborns with congenital heart defects
This study is testing a new way to monitor oxygen levels in newborns with congenital heart defects to see how it can help doctors understand their heart and blood flow better.
-
Registry for adults with congenital heart disease in Switzerland
This study is collecting information from adults with congenital heart disease in Switzerland to better understand their health and improve their treatment options.
-
Evaluation of a heart valve for patients with pulmonary valve dysfunction
This study tests a new heart valve to see if it can safely help people with problems in their pulmonary valve or right ventricular outflow tract.
-
Personalized E-Fit program to help executive skills in kids with complex congenital heart disease
A tailored digital training program called E-Fit tests whether targeted brain-training, online coaching, and hands-on games can improve everyday executive skills in 9- to 13-year-olds who have complex congenital heart disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.